Multi Vessel Disease
Ensure cost-efficiency in your Multi-vessel Disease cases.
Multi-vessels coronary artery disease (CAD) is a disease stage in which at least two or three of the epicardial coronary arteries is involved with atherosclerosis of significant severity.
The goal in the treatment of multi-vessel disease is to reduce angina and heart failure symptoms.
The FAME study demonstrated that routine measurement of FFR (Fractional Flow Reserve) during DES-stenting in patients with multi-vessel disease is superior to current angiography guided treatment and improves outcome of PCI significantly.
From a short time, we also see some non Hyperemic index's been developed such as DFR™. The goal of these indexs are to avoid injection of adenosine. It may reduce cost and duration procedure. It also may lead to assess patient who are contraindicated to FFR.
Emerge™ Emerge PTCA Dilatation Catheter unites versatility and deliverability
Maverick2 ™ PTCA Balloon Catheters
NC Emerge™ PTCA Dilatation Catheter
NC Quantum Apex™ PTCA Dilatation Catheter
Convey™ PTCA Dilatation Catheter
GUIDEZILLA™ II Guide Extension Catheter
MACH 1™ Guide Catheter
RUNWAY™ Guide Catheter
SENTAI™ Specialty Crossing Wires
SENTAI™ Workhorse Wires
CHOICE™ Extra Support Guidewire
CHOICE™ Floppy Guidewire
CHOICE™ PT Extra Support Guidewire
CHOICE™ PT Floppy Guidewire
PT GRAPHIX™ Intermediate Guidewire
PT²™ Light Support Guidewire
PT²™ Moderate Support Guidewire
COMET™ Pressure Guidewire
SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System